Cyta Therapeutics
PrivateLast Round
Accelerator
Sep 5, 2023
Company Overview
Cyta Therapeutics is a biotechnology company developing proprietary polymer-based nanogel delivery systems for the treatment of obesity and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyta Therapeutics Comparables
Compare Cyta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hepagene Therapeutics | 78% | |
| Aligos Therapeutics | 77% | |
| Ascletis Pharma Inc. | 77% | |
Cyta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 5, 2023 | ||||
| Grant | Feb 11, 2022 |
Cyta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Innovation Space | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 52% MoM.
- Feb 11, 2022
Received grant funding to support operations.
Cyta Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cyta Therapeutics's valuation, stock price, and market status.